Search
01/04/2025
Enhancing health equity considerations in guidelines: health equity extension of the GIN-McMaster Guideline Development Checklist
Dewidar, O, Say, S, Pardo, JP, Welch, V, Wright, GC, Akl, EA, Khabsa, J, Lin, JS, Wang, XQ, Darzi, AJ, Lot, T, Pottie, K, Khawandi, J, Morgan, RL, Pinto, ACPN, Tufte, J, Brennan, SE, Motilall, A, Oloyede, O, Mustafa, RA, Petkovic, J, Nieuwlaat, R, Xia, J, Yao, XM, Chi, Y, Schünemann, HJ, Tugwell, P. Enhancing health equity considerations in guidelines: health equity extension of the GIN-McMaster Guideline Development Checklist. Eclinicalmedicine. 2025; 82DOI:10.1016/j.eclinm.2025.103135. PMID:40224676. IF:10.000(Q1/1D).
01/04/2025
Sexual dysfunction in women with breast cancer: a systematic review
Rodrigues-Machado, N, Bonfill-Cosp, X, Quintana, MJ, Santero, M, Bártolo, A, Olid, AS. Sexual dysfunction in women with breast cancer: a systematic review. SUPPORTIVE CARE IN CANCER. 2025; 33(4)DOI:10.1007/s00520-025-09352-6. PMID:40163251. IF:3.000(Q1/1D).
26/03/2025
Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA
Tibau, A, Hwang, TJ, Romano, A, Borrell, M, Gich, I, Molto, C, Kesselheim, AS. Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA. JAMA Network Open. 2025; 8(3)DOI:10.1001/jamanetworkopen.2025.2026. PMID:40136298. IF:9.700(Q1/1D).
01/03/2025
A call for improving the internal validity and the reporting of manual therapy trials self-labelled as pragmatic: A methodological review
Roura, S, Alvarez, G, Hohenschurz-Schmidt, D, Sola, I, Núñez-Cortés, R, Bracchiglione, J, Fernández-Jané, C, Phalip, J, Gich, I, Sitjà-Rabert, M, Urrútia, G. A call for improving the internal validity and the reporting of manual therapy trials self-labelled as pragmatic: A methodological review. International Journal of Osteopathic Medicine. 2025; 55DOI:10.1016/j.ijosm.2025.100754. PMID:. IF:1.500(Q2/5D).